FDA tried to discredit research on Vioxx health risk
The US federal drugs regulator made spurious scientific claims in an attempt to prevent publication of an article detailing the health risks of the anti-inflammatory drug Vioxx, the editor of a
The US federal drugs regulator made spurious scientific claims in an attempt to prevent publication of an article detailing the health risks of the anti-inflammatory drug Vioxx, the editor of a